Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 922 | 64,358 | 14,967 | 1,784 | 1,784 |
| Gross Profit | 922 | 64,358 | 14,967 | 1,784 | 1,784 |
| Operating Expenses | 56,760 | 71,708 | 58,923 | 47,589 | 47,589 |
| Operating Income | -55,838 | -7,350 | -43,956 | -45,805 | -45,805 |
| Interest Expense | 260 | 278 | 218 | 348 | 348 |
| Other Income | 23 | 1,061 | 4,819 | 4,986 | 4,986 |
| Pre-tax Income | -56,075 | -6,567 | -39,355 | -41,167 | -41,167 |
| Income Tax | -1,139 | 0 | N/A | N/A | N/A |
| Net Income Continuous | -54,936 | -6,567 | -39,355 | -41,167 | -41,167 |
| Net Income | $-54,936 | $-6,567 | $-39,355 | $-41,167 | $-41,167 |
| EPS Basic Total Ops | -1.98 | -0.29 | -1.75 | -3.14 | -89.58 |
| EPS Basic Continuous Ops | -1.98 | -0.29 | -1.75 | -3.11 | -55.93 |
| EPS Diluted Total Ops | -1.98 | -0.29 | -1.75 | -3.14 | -89.58 |
| EPS Diluted Continuous Ops | -1.98 | -0.29 | -1.75 | -3.11 | -55.93 |
| EBITDA(a) | $-53,780 | $-5,218 | $-42,463 | $-44,568 | $-44,853 |